ACEA	N-(2-Chloroethyl)-5Z:8Z:11Z,14Z-eicosatetraenamid
ANVC	non-voiding contractions amplitude (cm H2O);
ATP	adenosine triphosphate citrate lyase (pg/mL);
AUC	the area under the pressure curve (cm H2O/s);
BC	bladder compliance (mL/cm H2O);
BDNF	brain-derived neurotrophic factor (pg/mL);
BP	basal pressure (cm H2O);
c-Fos	AP-1 transcription factor subunit (pg/mL);
CGRP	Calcitonin Gene-Related Peptide (pg/mL);
CRF	corticotropin-releasing factor (pg/mL);
DO	detrusor overactivity;
DOI	detrusor overactivity index (cm H2O/mL);
FNVC	non-voiding contractions frequency (times/filling phase);
ICI	intercontraction interval (s);
IL-1β	Interleukin 1-β (pg/mL);
IL-6	Interleukin-6 (pg/mL);
IL-10	Interleukin-10 (pg/mL);
MPA	medial preoptic area;
MVP	micturition voiding pressure (cm H2O);
NGF	nerve growth factor (pg/mL);
OAB	overactive bladder syndrome;
OCT3	Organic Cation Transporter 3 (pg/mL);
PMC	pontine micturition center;
PVR	post-void residual (mL);
ROCK	rho kinase (pg/mL);
TNF-	tumor necrosis factor alpha (pg/mL);
TP	threshold pressure (cm H2O);
TRPV1	Transient Receptor Potential Cation Channel Subfamily V, Member 1
VAChT	vesicular acetylcholine transporter (pg/mL);
vlPAG	ventrolateral periaqueductal gray;
VTNVC	volume threshold to elicit NVC (%);
VV	voided volume (mL).